 reduct graft failur monoclon antibodi hla nonident bone marrow transplant children immunodefici osteopetrosi fanconi anemia european group immunodeficiency/european group bone marrow transplant report forty-six infant children inherit immunodefici disord wiskott-aldrich syndrom function t-cell immunodefici hla class II express defici malign osteopetrosi fanconi anemia hla-nonident bone marrow transplant bmt donor bone marrow t-cell risk graft-versus-host diseas gvhd graft failur mous monoclon antibodi specif function-associ antigen molecul patient eleven patient infus mg/kg day day thirty-f patient mg/kg day overal sustain engraft rate histor control group patient infus antibodi late reject t-cell deplet method e-roset campath IM complement differ rate engraft engraft rate degre hla incompat donor recipi acut gvhd grade II patient rate chronic gvhd overal actuari surviv rate function graft mean follow-up month patient immunodefici osteopetrosi none patient fanconi anemia develop full t-cell function averag month full b-cell function month signific infecti problem major patient posttranspl cours epstein-barr virus-induc b-cell prolif syndrom patient wiskott-aldrich syndrom correct immunodefici compar term kinet qualiti patient sever immunodefici hla-nonident bmt correct osteopetrosi differ hla-ident bmt vivo use antibodi addit immunosuppress therapi hla-nonident bmt engraft surviv correct primari diseas signific number patient life-threaten immunodefici osteopetrosi fanconi anemia